GSS vs MYX

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

GSS

GENETICSIG FPO [GSS]

46LOW

MYX

M PHARMA FPO [MYX]

46LOW

Score Breakdown

GSS MYX
Technical
70
65
Catalyst
53
86
Sentiment
50
50
Fundamental
76
87
Momentum
24
33
Risk Gate
50
45

Key Metrics

GSS Metric MYX
$20.2MMarket Cap$187.7M
560KAvg Volume (20d)596K
N/AShort Interest+2.1%
$0.69052-Week High$7.295
$0.07052-Week Low$2.040
+11.2%Daily Change-0.9%
$0.089Entry Price$2.300
-22.8%ROE-20.6%
-56.5%Profit Margin-20.4%

Active Signals

GSS Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●On a tear — up 12.7% over the last 5 days
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (12 quarters)
●Low P/S ratio (1.0x)
●EPS estimates revised downward (-6pts)

MYX Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Volume surging at 2.4x normal while price falls — heavy selling pressure
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.5x)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare GSS and MYX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
GSS Full Analysis → MYX Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).